North America
Tags: Canada, European Union, Intellectual Property, Life SciencesThe New Patented Medicines (Notice of Compliance) Regulations and Certificate of Supplementary Protection Regulations
By Marie Lafleur, Fasken Martineau
The Comprehensive Economic and Trade Agreement (CETA) was signed by Canada and the European Union (EU) on October 30, 2016. The following day, the Canadian Government introduced legislation to amend Canadian laws for the purpose of bringing consistency between Canadian and European Union intellectual property laws and regulations …
Read more, download or share the PDF update below ..
Latest Updates
Related Articles
Related Articles by Jurisdiction
Claims that Involve a Fixed Dosage and Schedule Can Constitute Patentable Subject Matter
The Canadian Intellectual Property Office has issued a revised guidance which provides clear instructions on how to approach medical use claims and determine whether such claims are eligible for patent protection.
Private right of action under Canada’s Anti-Spam Law
As of July 1, 2017, individuals and organizations will be entitled to institute a "private right of action" before the courts against those that contravene certain provisions of Canada's Anti-Spam Law ...
Significant changes proposed to Canada’s AML/ATF regime
The Proposed Regulations are wide ranging and include a number of substantive changes as well as technical amendments.
Latest Articles
